Sign in
4/A

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-20-139275

Options or other derivatives

  • Chief Operating Officer acquired 63,004 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jacobson Mark L. · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-17 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +48,237 48,237 D
2020-03-17 Grant or award : show line 2 in the form Restricted Stock Units +14,767 14,767 D
Loading xslF345X03/tm2039202-2_4seq1.xml…